You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 99 No. 6, JUNE 1957 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (9)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

MALIGNANT CARCINOID a new metabolic disorder

ALBERT SJOERDSMA, M.D., Ph.D.; LUTHER L. TERRY, M.D.; SIDNEY UDENFRIEND, Ph.D.

AMA Arch Intern Med. 1957;99(6):1009-1012.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

Carcinoid is a relatively benign tumor of the gastrointestinal tract and is thought to originate from the chromaffin cells in the mucosa. Although most commonly located in the appendix, carcinoids have been found from the cardia of the stomach to the rectum. Occasionally these tumors become more malignant and invade adjacent tissues and metastasize to the liver and other distant organs. Histologically no differentiation can be made between the small, apparently benign lesion and the distant metastatic tumors. Thus, many workers feel that all carcinoid lesions are potentially malignant. Although most carcinoids are discovered incidentally at the time of surgery or autopsy, it is now apparent that some carcinoids produce a variety of clinical manifestations through secretion of the pharmacologically active agent, serotonin (5-hydroxytryptamine).

Clinical Manifestations

Recently an unusual clinical syndrome has been described which is associated with "malignant" carcinoid of the small intestine and metastasis to the . . . [Full Text PDF of this Article]


Author Affiliations

Bethesda, Md.

From the Clinic of General Medicine and Experimental Therapeutics and Laboratory of Clinical Biochemistry National Heart Institute.


Footnotes

Submitted for publication Jan. 8, 1957.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1957 American Medical Association. All Rights Reserved.